(Q39848866)

15 September 2017

In vitro studies with R 51,211 (itraconazole) (English)

1 reference

https://api.crossref.org/works/10.1128/AAC.26.1.5

15 September 2017

1 reference

2 August 2023

author name string

A. Espinel-Ingroff

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6089654

2 August 2023

S. Shadomy

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6089654

2 August 2023

R. J. Gebhart

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6089654

2 August 2023

language of work or name

English

0 references

publication date

1 July 1984

1 reference

PMC publication ID

179904

full work available at URL

15 September 2017

https://europepmc.org/articles/PMC179904

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6089654

https://europepmc.org/articles/PMC179904?pdf=render

2 August 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6089654

https://journals.asm.org/doi/pdf/10.1128/AAC.26.1.5

2 August 2023

1 reference

https://api.crossref.org/works/10.1128/AAC.26.1.5

Antimicrobial Agents and Chemotherapy

2 August 2023

published in

1 reference

15 September 2017

26

1 reference

15 September 2017

1

1 reference

15 September 2017

5-9

1 reference

Azole resistance in Candida albicans.

15 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=179904

In-vitroinhibitory activities of 2 new orally absorbable imidazole derivatives: Bay n 7133 and bay l 9139

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=179904

In vitro comparison of the antifungal activities of R34,000, miconazole and amphotericin B

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=179904

Comparison of the in vitro antifungal activities of miconazole and a new imidazole, R41,400.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=179904

Oxiconazole, a new imidazole derivative. Evaluation of antifungal activity in vitro and in vivo.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=179904

Experimentelle Befunde über ein neues, oral wirksames Antimykotikum mit breitem Wirkungsspektrum

20 August 2018

1 reference

12 December 2020

Preparation and antimycotic properties of derivatives of 1-phenethylimidazole

1 reference

12 December 2020

Laboratory evaluation of antifungal agents: a comparative study of five imidazole derivatives of clinical importance

1 reference

12 December 2020

In-vitro studies with four new antifungal agents: BAY n 7133, bifonazole (BAY h 4502), ICI 153,066 and Ro 14-4767/002

1 reference

12 December 2020

A comparison of bifonazole (BAY H 4502) with clotrimazole in vitro

1 reference

12 December 2020

Antifungal activity in vitro of Ro 14-4767/002, a phenylpropyl-morpholine

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.26.1.5

1 reference

15 September 2017

1 reference

PMC publication ID

179904

15 September 2017

1 reference

PMC publication ID

179904